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Abstract. 
 
Plakoglobin regulates cell adhesion by pro-
viding a modulatable connection between both classical 
and desmosomal cadherins and their respective cyto-
 
skeletal linker proteins. Both plakoglobin and the related 
 
protein 
 
b
 
-catenin are posttranscriptionally upregulated 
 
in response to 
 
Wnt-1
 
 in cultured cells. Upregulation of 
 
b
 
-catenin has been implicated in potentiating hyper-
proliferation and tumor formation. To investigate the 
role of plakoglobin in these functions we expressed a 
 
full-length (PG) and an NH
 
2
 
-terminally truncated form 
of plakoglobin (
 
D
 
N80PG) in mouse epidermis and hair 
follicles, tissues which undergo continuous and easily 
observed postnatal renewal and remodeling. Expres-
sion of these constructs results in stunted hair growth, a 
phenotype that has also been observed in transgenic 
mice expressing 
 
Wnt3
 
 and 
 
Dvl2 
 
(Millar et al., 1999). 
Hair follicles from PG and 
 
D
 
N80PG mice show prema-
ture termination of the growth phase (anagen) of the 
hair cycle, an event that is regulated in part by FGF5 
(Hebert et al., 1994). The proliferative rate of the epi-
dermal cells was reduced and apoptotic changes, which 
are associated with entry into the regressive phase of 
the hair follicle cycle (catagen), occurred earlier than 
usual.
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Introduction
 
Plakoglobin, 
 
b
 
-catenin, and 
 
Drosophila
 
 Armadillo are
closely related multifunctional proteins that regulate cell
adhesion and participate in signal transduction cascades.
All three proteins provide modulatory links in a chain of
proteins that connect cadherin cell adhesion molecules to
the actin filaments of adherens junctions. Plakoglobin dif-
fers from 
 
b
 
-catenin and Armadillo in its additional role in
desmosomes, where it binds strongly to desmosomal cad-
herins and weakly to desmoplakins and intermediate fila-
ments (for reviews, see Cowin and Burke, 1996; Kowal-
czyk et al., 1997; Smith and Fuchs, 1998; Cowin, 1999).
Plakoglobin, 
 
b
 
-catenin, and Armadillo are also found in
cytoplasmic and nuclear complexes that integrate signals
from 
 
Wnt/wingless 
 
(
 
wg
 
)
 
1
 
 
 
proto-oncogenes and the 
 
ade-
nomatous polyposis coli 
 
(APC) tumor suppressor protein
to direct cell fate and govern aspects of cell proliferation
(Miller and Moon, 1996; Ben-Ze’ev and Geiger, 1998;
Gumbiner, 1998; Cowin, 1999). By analogy to the 
 
wg 
 
path-
way in flies, one model for vertebrate 
 
Wnt
 
 signaling posits
that secreted Wnts bind to specific members of the Friz-
zled transmembrane receptor family, resulting in recruit-
ment of cytosolic disheveled (Dvl) proteins to the plasma
membrane and inactivation of glycogen synthase kinase
(GSK-3
 
b
 
; Bhanot et al., 1996; Wang et al., 1996; He et al.,
1997). GSK-3
 
b
 
 normally acts as part of a protein complex
that promotes a series of posttranslational modifications
that target cytoplasmic 
 
b
 
-catenin for proteosomal degra-
dation (Rubinfeld et al., 1996; Yost et al., 1996; Aberle et
al., 1997; Orford et al., 1997; Zeng et al., 1997). Thus, Wnt
inactivation of GSK-3
 
b
 
 causes 
 
b
 
-catenin to accumulate,
translocate to the nucleus, bind to Tcf/Lef transcription
factors and regulate target genes such as 
 
c-myc
 
 and 
 
cyclin
D
 
 (Funayama et al., 1995; Karnovsky and Klymkowsky,
1995; Love et al., 1995; Behrens et al., 1996; Molenaar et
al., 1996; Van de Wetering et al., 1997; Bauer et al., 1998;
Cavallo et al., 1998; He et al., 1998; Roose et al., 1998;
Waltzer and Bienz, 1998; Tetsu and McCormick, 1999).
Experiments in rodent mammary and neuropheochro-
mocytoma cells have shown that 
 
Wnt-1 
 
expression upregu-
lates both plakoglobin and 
 
b
 
-catenin (Bradley et al., 1993;
Hinck et al., 1994). In addition, injection of either 
 
b
 
-cate-
nin or plakoglobin mRNAs into 
 
Xenopus
 
 embryos results
 
Address correspondence to Dr. Pam Cowin, Department of Cell Biology,
New York University Medical School, 550 First Ave., New York, NY
10016. Tel.: (212) 263-8715. Fax: (212) 263-8139/8752. E-mail: cowinp01
@med.nyu.edu
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
G, 
 
b
 
-globin sequence; APC, 
 
ade-
nomatous polyposis coli
 
; Dvl, disheveled; K14, keratin 14; KGM, kerati-
nocyte growth medium; TdR, [
 
3
 
H]thymidine; TUNEL, terminal deoxynu-
 
cleotidyl transferase-mediated dUTP nick end labeling; TX-100, Triton
X-100; 
 
wg
 
, 
 
Wnt/wingless. 
The Journal of Cell Biology, Volume 149, 2000 504
 
in the identical 
 
Wnt-1
 
 phenotype, axis duplication (McMa-
hon and Moon, 1989; McCrea et al., 1993; Karnovsky and
Klymkowsky, 1995). These results implicate both plako-
globin and 
 
b
 
-catenin as effectors of 
 
Wnt
 
 signals. Whether
plakoglobin directly transduces 
 
Wnt
 
 signals or acts to
modulate 
 
b
 
-catenin’s functionality is currently an area of
debate (Merriam et al., 1997; Miller and Moon, 1997; Wil-
liams et al., 1998). The late embryonic-lethal phenotype of
plakoglobin null mice and the inability of endogenous pla-
koglobin to rescue the early embryonic-lethal phenotype
of 
 
b
 
-catenin null mice suggest that plakoglobin does not
play a significant role in 
 
Wnt
 
 pathways governing early de-
velopment (Haegel et al., 1995; Bierkamp et al., 1996).
However, the participation of plakoglobin as a mediator of
Wnts in tissues that undergo significant postnatal develop-
ment and renewal has not been investigated. Formation of
the epidermal appendages of hair, feathers, and mammary
gland are therefore excellent models in which to study this.
In adults, inappropriate activation of elements in this
type of 
 
Wnt
 
 signaling cascade has been linked to a number
of cancers and several studies implicate 
 
b
 
-catenin in this
process. Mutations in the 
 
b
 
-catenin gene that result in a
stabilized protein product occur in colonic, gastric, hepato-
cellular, and hair follicle tumors and melanomas (Mune-
mitsu et al., 1995; Rubinfeld et al., 1997; Chan et al., 1999).
Overexpression of 
 
b
 
-catenin in vivo increases the prolifer-
ative rate of crypt cells and induces polyp formation in in-
testine and induces hair follicle formation and benign tu-
mors in skin (Gat et al., 1998; Wong et al., 1998; Harada et
al., 1999). The role of plakoglobin in proliferation and can-
cer is less well documented. However, several facts suggest
that plakoglobin may act as a tumor suppressor. For exam-
ple, the plakoglobin gene lies in the 17q-21 locus, which is
subject to loss of heterozygosity in human breast tumors
(Aberle et al., 1995). Plakoglobin is absent in a number of
tumor cell lines, and experimentally induced overexpres-
sion of plakoglobin in highly transformed cells decreases
their tumorigenicity (Navarro et al., 1991; Sommers et al.,
1994; Aberle et al., 1995; Simcha et al., 1996).
To address the questions of whether plakoglobin acts to
transmit 
 
Wnt
 
 signals in adult tissues, and whether it pro-
motes or suppresses proliferation and tumor formation in
normal cells, we expressed two forms of plakoglobin in the
basal cells of mouse epidermis and hair follicles under the
control of the keratin 14 (K14) promoter. Our results show
that even modest expression of these transgenes reduces
the proliferative potential of the epidermal cells and sig-
nificantly decreases the length of the growth phase of the
hair follicle cycle, shortening hairs by 30%. This effect sug-
gests that plakoglobin participates in the transduction of
growth-suppressive signals to normal epithelial cells.
 
Materials and Methods
 
Plasmids and Transgene
 
Flag-tagged human plakoglobin cDNA (p163/7-PG) was produced by
PCR using hPG Ca 2.1 as template (GenBank accession number Z68228;
Franke et al., 1989). 20 cycles of standard PCR conditions of 1 min at
94
 
8
 
C, 1 min at 54
 
8
 
C, and 3 min at 72
 
8
 
C were carried out with forward oli-
gonucleotide (5
 
9
 
-ccggaattcgccgcc
 
ATGGACTACAAGGACGACATGA-
CAAG
 
ATGGAGGTGATGAACCTG-3
 
9
 
), which contains an EcoRI re-
striction site, Kozac’s sequence, a sequence encoding the Flag epitope
 
(
 
MDYKDDDDK
 
) and the first five amino acids of hPG, and reverse oli-
gonucleotide (5
 
9
 
-ccggaattcCTAGGCCAGCATGTGGTC-3
 
9
 
) that con-
tains an EcoRI restriction site and the last 18 bases of the hPG Ca 2.1 cod-
ing sequence including the stop codon. The PCR product was subcloned
into the EcoRI restriction site of the p163/7 expression vector (Niehrs et
al., 1992) containing the MHC class I H-2 promoter, a polylinker embed-
ded in rabbit 
 
b
 
-globin sequence (
 
b
 
G; last 20 bp of exon 2, entire intron 2
and the polylinker dividing exon 3) and both 
 
b
 
G and SV-40 polyadenyla-
tion signals, generating p163/7-PG. The transgene construct, pK14-
 
b
 
G-
Flag-PG (see Fig. 1) was generated by introducing a BamHI linker into
the NotI site of the p163/7 polylinker downstream of Flag-hPG. This per-
mitted excision and insertion of a 2,935-bp BamHI fragment containing 5
 
9
b
 
G sequence and Flag-hPG into the BamHI site of a keratin 14 cassette,
which was kindly provided to us by Dr. Elaine Fuchs (University of Chi-
cago; see Fig. 1).
A cDNA encoding a myc-tagged stabilized form of plakoglobin deleted
in the first 80 amino acids was generated by PCR. A 531-bp DNA frag-
ment was amplified using hPG Ca 2.1 as template and forward oligonucle-
otide (5
 
9
 
-ctcgcggccgcggatccgaattcgccgcc
 
ATGGAGCAAAAGCTTATTT-
CTGAAGAGGACTTG
 
AGGGCCAAACGGGTGCGGAG-3
 
9
 
), which
contains NotI, BamHI, and EcoRI restriction sites, Kozac’s sequence, se-
quence encoding the myc epitope (
 
MEQKLISEEDL)
 
 and amino acids
81–87 of hPG, and the reverse oligonucleotide 817 Rev (5
 
9
 
-GCTGAG-
CATGCGGACCAGAGC-3
 
9
 
) encompassing the internal SphI at base
698 of hPG Ca 2.1. The 863-bp NotI-SphI fragment of hPG Ca 2.1 was re-
placed by the 519-bp NotI-SphI PCR fragment to generate pBS-
 
D
 
N80PG
from which the 3,192-bp EcoRI fragment was excised and subcloned into
p163/7 generating p163/7-
 
D
 
N80PG. A 2,798-bp BamHI fragment contain-
ing 
 
b
 
G-
 
D
 
N80PG was excised from the latter construct and subcloned into
the keratin 14 transgene vector generating pK14-
 
D
 
N80PG. The PCR gen-
erated regions and newly generated cloning sites of all clones were fully
sequenced by the dideoxy termination method (Sanger et al., 1977).
Plasmid DNA was prepared by alkaline lysis followed by double band-
ing on CsCl gradients. The K14-PG and K14-
 
D
 
N80PG transgenes (see Fig.
1 a) were excised from the pGEM 3Z backbone with KpnI, which cuts in
the 5
 
9
 
 polylinker and NdeI, which cuts at base 2.083 within the K14 3
 
9
 
 non-
coding sequence, leaving a 327-bp segment after the polyadenylation sig-
nal provided by the hGH sequences.
 
Southern Blot Analysis of Genomic DNAs
 
Genomic DNA was prepared by digesting 0.5 cm of mouse tail in 10 mM
Tris-HCl (pH 8.0), 1 mM EDTA, 20 mM NaCl, 1% SDS, and 1 mg/ml of
proteinase K for 12 h at 55
 
8
 
C followed by two ethanol precipitations. For
Southern blot analysis, 10–20 
 
m
 
g of genomic DNA samples were digested
with 80 units of BamHI and separated by electrophoresis in an 1
 
3
 
 TAE-
0.8% agarose gel at 3 V/cm. After UV cleavage, denaturation, and neu-
tralization, samples were transferred to Nytran membranes (Schleicher
and Schuell). Blots were prehybridized for 2 h at 68
 
8
 
C in a solution of 6
 
3
 
SSC, 1% SDS, 1
 
3
 
 Denhardt’s, and 125 
 
m
 
g/ml of denatured tRNA and hy-
bridized for 12 h in the same buffer containing 50 ng of random primed
 
a
 
-
 
32
 
P-plakoglobin cDNA probe, specific activity 10
 
9 
 
cpm/ug (ICN). Blots
were washed twice in 2
 
3
 
 SSC, 0.1% SDS, for 20 min each at 68
 
8
 
C and ex-
posed for 12 h to PhosphorImager screens (Molecular Dynamics).
 
Transfection, Immunoprecipitation, and Western
Blot Analysis
 
Human kidney cells transformed with SV-40 T-antigen (293T) were main-
tained, transfected, and immunoprecipitated as described (Witcher et al.,
1996). Forty 30-
 
m
 
m cryosections of tail from 25-d F1 transgenic and nor-
mal sex-matched littermates were boiled in 200 
 
m
 
l of 25 mM Tris-HCl, pH
7.4, 3 mM EDTA, 150 mM NaCl, 1% SDS, 10 
 
m
 
g/ml aprotinin, and 1 mM
PMSF and diluted in 1 ml of 2% Triton X-100 (TX-100) in 50 mM Tris-
HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, and 10 
 
m
 
g/ml aprotinin, 1 mM
PMSF. Insoluble debris was pelleted for 15 min at 10,000 
 
g
 
 and processed
for immunoprecipitation as described (Witcher et al., 1996). Protein con-
centration was determined by the method of Bradford using a BCA
(bicinchronic acid) protein assay kit (Pierce). Protein samples and immu-
noprecipitations were separated by electrophoresis through 7.5% SDS-
PAGE, electrophoretically transferred to Protran membranes (Schleicher
and Shuell) and blocked by incubation in PBS containing 0.1% Tween 20
and 5% nonfat dried milk. The blots were incubated with the following
mouse monoclonal antibodies: M2 anti-flag (Sigma) 9E10 anti-myc (a
kind gift of Dr. Harold Varmus, NIH, Bethesda, MD), PG5172 anti-plako-
globin (Cowin et al., 1986); anti–
 
b
 
-catenin, anti–GSK-3
 
b
 
, anti–E-cadherin 
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(Transduction Laboratories), anti-ribophorin antibody (a kind gift of Dr.
Gert Kreibich, NYU Medical School, NY). The primary antibody incuba-
tions were performed overnight at a dilution of 1:4,000 in PBS containing
0.1% Tween 20 and 5% nonfat dried milk followed by 1 h incubation with
peroxidase-coupled goat anti–mouse IgG diluted 1:6,000 in the same buffer
(Kirkegaard and Perry Laboratories Inc.). Blots were washed three times
for 15 min in PBS-Tween after each antibody and the immune complexes
were detected by ECL chemiluminescence (Amersham International).
 
Reporter Assays
 
293T cells were transfected as described (Witcher et al., 1996) with combi-
nations of 2 
 
m
 
g PG, 
 
D
 
N80Pg, and Lef1 cloned into the pCDNA3 vector,
together with 1 
 
m
 
g of pGL3-Topflash Tcf/Lef-responsive luciferase re-
porter gene or a control pGL3-Fopflash in which the Tcf-responsive ele-
ments have been mutated (Van de Wetering et al., 1997). 1 
 
m
 
g of CMV-
 
b
 
-gal was included as a control for transfection efficiency. All samples
were made up to a total of 6 
 
m
 
g DNA by addition of empty vector DNA.
HaCaT keratinocytes (Boukamp et al., 1988) were transfected with one
quarter of the above using Lipofectamine plus according to the manufac-
turer’s instructions (GIBCO BRL). Cells were extracted using a kit that
permitted luciferase and 
 
b
 
-galactosidase measurements to be made on the
same extracts according to the manufacturer’s instructions (Promega).
 
Indirect Immunofluorescence
 
Tail and back skin biopsies, respectively, from F1 transgenic and normal
sex-matched littermates were snap frozen in liquid nitrogen and stored at
 
2
 
70
 
8
 
C. 5-
 
m
 
m frozen sections were attached to multiwell slides and al-
lowed to air dry overnight at room temperature. Primary cultured kerati-
nocytes were fixed for 5 min in acetone/methanol (1:1) at –20
 
8
 
C then al-
lowed to air dry. The sections and cells were incubated with primary
antibodies diluted 1:50 in PBS, washed three times for 10 min each in PBS
then incubated with Alexa-conjugated goat anti–mouse or anti–rabbit IgG
diluted 1:200 (Molecular Probes). After three washes in PBS, the slides
were mounted in Gelvatol and the sections examined by epifluorescence
with a Zeiss axiophot photomicroscope III. The primary antibodies used
were DP2.15 anti-desmoplakin (Cowin et al., 1985); PG5172 anti-plako-
globin (Cowin et al., 1986); anti–
 
b
 
-catenin and anti–
 
g
 
-catenin (H80) NH
 
2
 
-
terminal plakoglobin antibody (Santa Cruz Biotechnology), anti–E-cad-
herin (Transduction Laboratories), and 9E10 anti-myc. Individual rabbit
anti–mouse K14, K5, K1, K6, and loricrin were used at dilutions of 1:100
(kindly provided by Dr. Stuart Yuspa, NCI, Bethesda, MD). Mouse mono-
clonal antibody AE14 anti-high sulfur protein was the gift of Dr. Michael
O’Guin (NYU School of Medicine, NY).
 
Tissue Histology and Measurement of Hair Follicles
and Hairs
 
Biopsies of mouse skin taken from the middle of the back were fixed over-
night or longer in 10% phosphate-buffered formalin, progressively dehy-
drated through gradients of alcohol, and embedded in paraffin. 5-
 
m
 
m sec-
tions were cut, deparaffinized in xylene, rehydrated, and then stained with
hematoxylin and eosin. The lengths of five hair follicles were measured on
sections from two to three pairs of F1 transgenic and normal sex-matched
mice per line taken at various time intervals over the 41-d period covering
the first two hair cycles (Wilson et al., 1994). Histological sections were
viewed and photographed on an Olympus Vanox X microscope using Ko-
dachrome II, ASA 25 film. Pelage hairs were plucked from the heads of
three pairs of 25-d F1 transgenic and control sex-matched littermates, and
individually attached to microscope slides with double-sided tape. 100
hairs were examined to determine the percentage of each hair type. 5–10
hairs of each type from 3–6 pairs of normal and transgenic littermates per
line were scanned. The length of each hair was measured with the aid of
Adobe Photoshop and NIH programs. The average length and standard
deviation were calculated and the Student’s 
 
t
 
 test was performed.
 
Keratinocyte Cell Culture
 
Primary epidermal keratinocytes were established in vitro as follows using
modifications of the method of Hennings (Hennings et al., 1980; Dlugosz
et al., 1995). Newborn mice were killed, then washed in a 1:10 solution of
Betadine, rinsed twice in sterile dH
 
2
 
O and twice in 70% alcohol. The skin
was removed and floated overnight on 2 ml of dispase (Dispase II, 25 U/ml;
Boehringer Mannheim). The epidermis was detached from the dermis,
 
minced and placed in 2 ml of 0.05% trypsin and 0.01% EDTA for 15 min at
37
 
8
 
C. DNase I (100 units) was added and the cells were mechanically disso-
ciated by vigorous pipetting followed by filtration through two layers of
sterile gauze. The cells were washed in an equal volume of DME containing
10% FCS to inhibit the trypsin and plated in low Ca
 
2
 
1
 
 keratinocyte growth
medium (KGM; Clonetics-Biowhittaker) adjusted to 0.05 mM Ca
 
2
 
1
 
 by ad-
dition of Ca
 
2
 
1
 
-free KGM.
 
Sequential Detergent Extraction of Epidermal Proteins
Primary keratinocytes were grown to confluence on 60-mm dishes under
low Ca21 conditions (0.05 mM) to maintain a basal cell phenotype then
switched to high (2 mM) Ca21 for 24 h to permit cell junction formation
(Hennings and Holbrook, 1983). Cellular proteins were extracted sequen-
tially in saponin buffer (0.01% saponin, 10 mM Tris, pH 7.5, 140 mM
NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM PMSF, and 10 mg/ml aprotinin)
and then in TX-100 buffer (1% TX-100, 10 mM Tris-HCl, pH 7.5, 140 mM
NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM PMSF, and 10 mg/ml aprotinin)
as described (Palka and Green, 1997), with the exception that extracts
were centrifuged for 1 h at 100,000 g.
Pulse–Chase
100-mm dishes of transgenic keratinocytes grown as described above were
starved for 1 h in methionine/cysteine-free DME then metabolically la-
beled with methionine/cysteine-free DME containing 0.5 mCi 35S-methi-
onine/cysteine/ml for 20 min. The cultures were rinsed with DMEM con-
taining 1,000-fold excess of cold methionine and incubated in this medium
for the time periods indicated. The cells were harvested, boiled in 1%
SDS, and immunoprecipitated as described above.
Determination of Single and Double
Pulse-labeled Keratinocytes
The method was carried out as described (Lehrer et al., 1998). 4-d-old
mice were injected subcutaneously with 50 mg of BrdU per gram body
weight. After a 24-h chase period, long enough for the BrdU-labeled cells
to traverse into a second S phase, the same animals were injected with 10
mCi/g of [3H]thymidine (TdR) and killed 60 min later. Backskin was re-
moved, fixed in 70% ethanol, 50 mM glycine for 24 h, embedded in paraf-
fin and sectioned at 5 mm. After deparaffination and rehydration, tissue
sections were processed for immunochemical staining with anti-BrdU an-
tibody and alkaline phosphatase-conjugated goat anti–mouse IgG (5-
bromo-29-deoxy-uridine labeling and detection kit II, Boehringer Mann-
heim Corp.), followed by visualization with the Vector® Red alkaline
phosphatase substrate kit I (Vector Laboratories Inc.) according to the
manufacturer’s instructions. Slides were air dried overnight, coated in nu-
clear track emulsion (Ilford K-2; Ilford) diluted 1:3 in distilled water at
408C, air dried again for 2 h, and exposed for 14 d at 48C in light tight
boxes containing anhydrous CaSO4 (Hamond Drierite). Autoradiographs
were developed as described previously (Lehrer et al., 1998). Slides were
lightly counterstained with hematoxylin. All slides were examined under
oil immersion (363) with a Zeiss Axiophot light microscope. A cell was
considered double labeled if it contained greater than five silver grains per
nucleus over a bright nuclear pattern of red staining. The epidermal label-
ing index was determined by counting the number of 3H-TdR–stained nu-
clei per 1,000 basal nuclei. The percentage of BrdU-labeled cells that were
additionally labeled with 3H-TdR was also determined (Lehrer et al.,
1998).
Terminal Deoxynucleotidyl Transferase-mediated dUTP 
Nick End Labeling Analysis
The terminal deoxynucleotidyl transferase-mediated dUTP nick end la-
beling (TUNEL) analysis was performed on 5-mm formalin fixed paraffin-
embedded mouse backskin sections using the Promega Fluorescein Apop-
tosis Detection System.
Results
Generation of Transgenic Mice
Previous studies on the signaling function of b-catenin em-
ployed full-length and NH2-terminally deleted forms ofThe Journal of Cell Biology, Volume 149, 2000 506
Figure 1. PG and  DN80PG
transgenes. (a) Luciferase re-
porter assays. 293T cells and
HaCat keratinocyte cultures
were transfected with 1 mg
pTOPFLASH (Top) or 1
mg pFOPFLASH (Fop) 1 mg
CMV-Lac Z with or without
2 mg PG (P), DN80PG (D),
Lef-1 (L) cloned in pCDNA3
or pCDNA3 (V). Luciferase
activity expressed in light
units represents an average
of three samples, with stan-
dard deviations shown in
bars after correction for
transfection efficiency as
measured by b-galactosidase
activity. (b) Diagram of the
K14-PG and K14-DN80PG
transgene constructs com-
prising the K14 promoter
(K14P), hGH  intron/exon/
polyadenylation sequences
(int/ex pA) and K14 39 non-
coding sequence. Sequence
encoding the NH2- and
COOH-terminal domains
and 13 central armadillo
(arm) repeats of the PG and
DN80PG cDNA are repre-
sented by shaded rectangles.
B, BamHI; E, EcoRI, K,
KpnI; N, Not1; Nde, NdeI.
Southern blot detection of
K14-PG and K14-DN80PG
transgenes in the genome of
transgenic lines hybridized
with the 32P-labeled PG in-
sert and mouse engrailed
gene (en) fragments. Lanes
marked 100 and 10 show re-
spective copy equivalents of
PG and DN80PG transgene
plasmid. The arrow points to
a 3-kb DNA marker. Lanes
marked nos. 21, 24, 4, 9, and
45 show DNA from these re-
spective transgenic mouse
lines. Expression of the
transgene products detected
by indirect immunofluorescence. Frozen sections of 5-d (c) or newborn tail skin (d) and 5-d backskin (e–f) stained with anti-flag (c) or
anti-myc (d–f) antibody detect the PG (c) and DN80PG (d–f) transgene products. Strongest staining is seen at the intercellular borders
of the basal layer of transgenic epidermis and continuous layers of the outer root sheath (ORS) of developing hair follicles (c–d) where
the K14 promoter is active. Note the horseshoe staining of the basal cells due to absence of reaction on hemidesmosomes (arrows).
Staining, representing the persistence of the transgene product in progeny of former K14-expressing cells, is also observed in suprabasal
layers of the epidermis (c–d) and in cells within the hair follicle bulbs lying next to the dermal papilla (DP) (e–f) where the K14 pro-
moter is not active.
b-catenin, which show enhanced stability (Munemitsu et al.,
1995). We therefore constructed analogous cDNAs encod-
ing an epitope-tagged full-length (PG) and NH2-terminally
deleted (DN80PG) form of plakoglobin and tested if the
products of these constructs retained transcriptional activity
by performing a luciferase reporter assay (Van de Wetering
et al., 1997). The products of both plakoglobin constructs
transactivated z100–200-fold a Topflash luciferase reporter
in the presence of a putative transcriptional partner Lef-1
(Fig. 1 a). This effect was observed in both 293T cells that
make few intercellular junctions and HaCaT keratinocytes
that contain many desmosomes (Boukamp et al., 1988).
Low levels of transactivation z10-fold of the Topflash re-
porter occurred in the absence of Lef-1 and presumably re-
sulted from activation of endogenous Lef/Tcf transcrip-
tional partners. Neither form of plakoglobin transactivatedCharpentier et al. Plakoglobin and Proliferation 507
the control Fopflash luciferase reporter construct which is
mutated in the Tcf/lef-responsive elements (Fig. 1 a).
To test the potential role of plakoglobin in regulating
cell proliferation, in vivo, we employed a K14 transgene
cassette, kindly provided to us by Dr. Elaine Fuchs, which
directs expression of transgenes under the control of the
K14 promoter to the basal layer of the interfollicular epi-
dermis and the outer root sheath of hair follicles (Guo et
al., 1993; Vassar et al., 1989). Both full-length K14-PG and
NH2-terminally deleted K14-DN80PG (Fig. 1 b) were used
to generate transgenic mice in the Swiss Webster strain.
Two mice (nos. 21 and 24) tested positive by Southern
analysis of tail genomic DNA for integration of the K14-
PG transgene and gave Mendelian transmission to the F1
generation. Seven mice tested positive for integration of
the K14-DN80PG transgene. Of these, nos. 1, 4, 45, 46
showed Mendelian transmission of the transgene to the F1
generation, nos. 5 and 9 showed ,10% transmission, sug-
gesting mosaicism, and no. 31 gave 75% transmission to
the F1 progeny, suggesting that the transgene inserted at
multiple sites in the genome. Immunofluorescence detec-
tion of the epitope tags on frozen sections of tail epidermis
indicated that expression of the transgene protein prod-
ucts occurred in one K14-PG founder (no. 21) and three
K14-DN80PG founders (nos. 4, 9, and 45). Significantly
only these four mice displayed hair phenotypes. Their F1
progeny were studied further in the experiments described
below.
Expression of the DN80PG Transgene
Southern analysis of tail genomic DNA from F1 mice with
probes derived from plakoglobin cDNA and a fragment of
the engrailed gene showed that lines nos. 21, 4, 9, and 45
Figure 2. Expression of the
transgene products detected
by indirect immunofluores-
cence. Frozen sections of tail
skin from newborn sex-
matched  DN80PG trans-
genic (a–d) and control (a9
and d9) F1 littermates. Anti-
myc antibody detects the
transgene product in trans-
genic skin (a and c) but gives
no reaction on normal skin
(a9 and c9). Strong staining is
seen at the intercellular bor-
ders of the basal layer of
transgenic epidermis and
contiguous outer root sheath
(ORS) of the hair follicle (a
and c) where the K14 pro-
moter is active. Note the
horseshoe staining of the
basal cells due to absence of
reaction on hemidesmo-
somes (arrows). Staining rep-
resenting the persistence of
the transgene product in
progeny of former K14-
expressing cells is observed
in suprabasal layers of the
epidermis (a and c) where
the K14 promoter is not ac-
tive. Note that the cellular lo-
calization of endogenous pla-
koglobin (b and b9), detected
with an antibody H-80 di-
rected against NH2-terminal
epitopes not present in the
transgene, or of endogenous
b-catenin (d and d9) is the
same in transgenic (b and d)
skin as in normal skin (b9 and
d9). DP, dermal papilla.The Journal of Cell Biology, Volume 149, 2000 508
carried 50, 40, 10, and 15 copies, respectively, of the trans-
gene, based on normalization and calibration to a series of
titrated plasmid controls (Fig. 1 b). Immunofluorescence
microscopy with anti-flag and anti-myc antibody on frozen
sections of F1 tails detected the epitope tags in transgenic
epidermis (Fig. 1, c and d) but not normal littermate epi-
dermis showing the strongest expression within the basal
layer. Staining was most obvious at the intercellular bor-
ders of keratinocytes reflecting the distribution of desmo-
somes and adherens junctions but was absent from the
basal borders where the cells contact the basal lamina via
hemidesmosomes (see arrows in Fig. 1, c and d). In trans-
genic mice from all four lines, expression was also seen
strongly in outer root sheath cells of the hair follicles (Figs.
1 d and 2 c). Staining was also observed in layers of the
epidermis and hair follicle, which do not express the K14
promoter. For example, staining was seen in suprabasal
epidermal cells (Figs. 1 d and 2, a and c), and in epithelial
cells of the hair follicle bulb including those surrounding
the dermal papilla (Fig. 1, e and f). This likely reflects per-
Figure 3 (continues on facing
page).Charpentier et al. Plakoglobin and Proliferation 509
sistence of the transgene protein product in progeny of
previously K14 positive stem cells. Weak staining was seen
in the cytoplasm of all positive cells, nuclear localization
was not generally observed in the transgenic tissue sec-
tions.
It has been argued in other systems that plakoglobin sig-
naling may be an indirect result of competitive displace-
ment of b-catenin from the membrane. To address this
possibility we compared the localization of endogenous
b-catenin plakoglobin in transgenic (Fig. 2, a–d) and nor-
mal skin (Fig. 2, a9–d9). Staining for endogenous plakoglo-
bin with an NH2-terminal antibody (Fig. 2, b and b9) and
for endogenous b-catenin with a COOH-terminal anti-
body (Fig. 2, d and d9) showed essentially similar patterns
in transgenic (Fig. 2, b and d) and normal (Fig. 2, b9 and
d9) epidermis and hair follicles.
Examination of mouse skin under the electron micro-
scope showed that transgenic skin contained desmosomes
with normal appearance and frequency demonstrating
that the transgene expression had no deleterious effect on
formation or stability of these cell junctions (Fig. 3, a and
b). Immunofluorescent staining of primary keratinocyte
cultures from the epidermis of transgenic mice showed
strong localization of the epitope tag at cell–cell borders
and faint cytoplasmic staining (Fig. 3 c). Strong reaction
was also observed in the nucleus of some but not all trans-
genic cultured keratinocytes (Fig. 3 c). These staining pat-
terns were specific for transgenic keratinocytes and were
not observed in cells derived from normal littermates (Fig.
3 c9). As predicted from previous studies, which showed
that the first 80 amino acids of plakoglobin are dispensable
for its interactions with all known partners (desmoglein,
desmocollin, E-cadherin, a-catenin, APC, and Lef/Tcf),
no perturbations were seen in the patterns of localization
of several major junctional proteins such as desmoplakins,
b-catenin, endogenous plakoglobin or E-cadherin (Fig. 3,
d–f and d9–f9) (for review, see Cowin and Burke, 1996).
Confirmation that the epitopes recognized by the an-
tibodies in the immunofluorescence assays above rep-
resented the PG and D80PG products encoded by the
transgene was obtained by cross-blotting anti-plakoglobin
immunoprecipitates with anti-flag or anti-myc antibody
(Fig. 4 a). In each case, a protein of the appropriate mass,
z86 kD for PG and 75 kD for D80PG, could be detected in
transgenic animals (lanes 2, 4, 6, and 8) but not in their
normal littermates (lanes 1, 3, 5, and 7). Primary kerati-
nocytes from normal and transgenic F1 mice were cultured
under low Ca21 conditions, which enrich for basal cells and
hence for cells expressing the K14 promoter (Hennings et
al., 1980; Dotto, 1998). After 2–3 d in culture the cells were
switched for 12 h to high Ca21 to permit cell-junction
formation (Hennings and Holbrook, 1983; Dotto, 1998).
Under these conditions, 100% of the cells express the
transgene product as judged by immunofluorescence mi-
croscopy. Equal amounts of protein from normal and
transgenic keratinocytes, as judged by protein estimation,
were processed for immunoblotting. Protein loading was
controlled by monitoring the expression level of ribo-
phorin, a resident protein of the endoplasmic reticulum
(Fig. 4 b). The level of transgene expression was found to
be z50% that of the endogenous protein in line no. 4. No
significant downregulation of the endogenous pool of pla-
koglobin or b-catenin was observed in the transgenic ke-
ratinocytes when compared with normal keratinocytes.
Figure 3. Electron micrographs show that desmosomes (arrows) occur with normal frequency and structural appearance in the basal
layers B, and superficial layers of normal (a) and transgenic (b) epidermis. Primary keratinocytes from newborn transgenic DN80PG (c–f)
and control (c9–f9) littermates were processed for indirect immunofluorescence microscopy. Anti-myc (myc) (c and c9), anti-plakoglobin
(pg) (d and d9), anti–b-catenin (bc) (e and e9), and anti-desmoplakin (dp) (f and f9) were used as primary antibodies. Note that the pres-
ence of the transgene product (c–f) causes no alterations in the localization of other junctional components (compare c–f with c9–f9).
Bars: (a and b) 0.5 mm; (c–f and c9–f9) 25 mm; (insets) 0.1 mm.The Journal of Cell Biology, Volume 149, 2000 510
containing buffers. GSK-3b and E-cadherin were used, re-
spectively, as markers of cytosolic and membrane-bound
fractions (Fig. 4 c). DN80PG was found in all three frac-
tions in the same relative proportions as endogenous pla-
koglobin. No changes were seen in the relative distribu-
tions of endogenous plakoglobin or b-catenin among these
subcellular fractions when normal mice were compared
with transgenics (Fig. 4 c).
In other studies, NH2-terminally deleted DN89 forms of
b-catenin have been shown to have increased stability due
to removal of critical phosphoserines that are required for
targeting for degradation (Munemitsu et al., 1995). In
transient expression experiments in 293T cells, we consis-
tently saw higher steady-state expression of DN80PG than
PG, suggesting that removal of this analogous domain may
increase the steady-state level of plakoglobin in a similar
fashion (Fig. 4 d). We examined the stability of the two
forms of plakoglobin by pulse–chase experiments on cul-
tured transgenic keratinocytes. However, in this cell type
we saw no obvious difference in the stability of the full-
length product as compared with the DN80PG product
(Fig. 4 e). While DN89-b-catenin has been expressed in
epidermal keratinocytes, its stability relative to full-length
b-catenin has not been assessed in this cell type (Gat et al.,
1998). Thus, at the present time it is not clear if there is
a fundamental difference in the mechanisms regulating
turnover of plakoglobin and b-catenin, or if keratinocytes
differ from colonic and 293T cells in regulating the activ-
ity of GSK-3b or other elements in the putative GSK-
3b–dependent degradation pathway. Regulated rather than
constitutive activity of GSK-3b has recently been reported
to occur in Dictyostelium discoideum (Kim et al., 1999).
Transgenic Mice Have Stunted Hair Growth
The striking feature that distinguished transgenic animals
of PG line no. 21 and all three DN80PG lines from their
normal littermates was a pronounced short hair phenotype
giving the mice a less fluffy appearance to their coat and a
pronounced pink hue (Fig. 5, a and b). Three founders
(nos. 21, 4, and 45) and the 50% of their offspring that car-
ried the transgene had dramatically shorter hair uniformly
throughout their pelt. Founder no. 9, however, showed
both short and long hair in banded and patchy fashion but
the 10% of F1 progeny from this line that were transgenic
showed the uniform short hair phenotype. These observa-
tions are consistent with the presence of the transgene
causing the shortening of the hair and with founder no. 9
having mosaic expression of the transgene within its epi-
dermis.
Transgenic F1 mice had a taut facial appearance and
prominent ears, features resulting in part from the short-
ness of the hair tufts found abundantly in the cheeks and
around the ears of normal mice. It was possible to accu-
rately identify transgenic mice from day 11 on the basis of
coat morphology. The short hair phenotype was most ob-
vious once the coat was well formed, between days 15–40,
the time span during which the first two highly synchro-
nized hair cycles occur in the mouse. Adult transgenic
mice remained distinguishable from wild-type littermates,
having a close-cut smooth coat, although the phenotype
became less obvious in the older mice probably due to the
Figure 4. Western blot analysis of PG and DN80PG protein ex-
pression in skin and keratinocytes. (a) Proteins from tail skin of
25-d sex-matched F1 normal mice (N) nos. 4, 9, 45, 21 (lanes 1, 3,
5, and 7, respectively), and their transgenic littermates (lanes 2, 4,
6, and 8, respectively) were immunoprecipitated then immuno-
blotted with anti-myc (lanes 1–6) and anti-flag (lanes 7 and 8) an-
tibodies. The arrowheads denote the migration of the 86-kD PG
and 75-kD DN80PG and transgene products. (b) Equal amounts
of total proteins, extracted from primary keratinocytes were blot-
ted with anti-ribophorin antibody as a loading control; anti-pla-
koglobin, anti–b-catenin, and anti–E-cadherin antibodies were
used to detect the endogenous proteins and anti-myc antibody to
detect the DN80PG as indicated. Expression of endogenous pla-
koglobin and b-catenin are not affected by expression of the
transgene but E-cadherin is slightly elevated. (c) Primary kerati-
nocytes were sequentially detergent extracted. Proteins soluble
in saponin (lanes 1 and 19) or TX-100 (lanes 2 and 29) and those
in the TX-100 insoluble pellet (lanes 3 and 39) were blotted with
anti–GSK-3b and anti–E-cadherin antibodies to control the frac-
tionation procedure. Anti-myc antibody detected the transgene
product DN80PG in the same relative proportions in all three
fractions as the endogenous plakoglobin. No differences were de-
tected in the relative partitioning of endogenous plakoglobin and
b-catenin as a result of transgene expression. (d) DN80PG shows
slightly higher levels of expression compared with PG when ex-
pressed in 293T cells. Total proteins extracted from metabolically
labeled 293T cells cotransfected with myc-Ta1 (transfection con-
trol) and either empty p163/7 vector (lane 1), p163/7-PG (lane 2),
or p163/7-DN80PG (lane 3), were divided in half and immuno-
precipitated with anti-plakoglobin antibody (top panel) or anti-
myc antibody (bottom panel). (e) Pulse–chase experiments.
Transgenic PG and DN80PG keratinocytes were metabolically
labeled with 0.5 mCi 35S-methionine/cysteine/ml for 20 min then
chased for the hours indicated above the lanes. Note that in pri-
mary keratinocytes both the full-length and NH2-terminally de-
leted forms of plakoglobin are stable.
However, we observed a slight increase in E-cadherin lev-
els in transgenics (Fig. 4 b). To determine the biochemical
partitioning of DN80PG protein, keratinocytes were se-
quentially extracted first in saponin and then in TX-100Charpentier et al. Plakoglobin and Proliferation 511
asynchrony of subsequent hair cycles. Heterozygous and
homozygous transgenic mice showed no increase in mor-
bidity or mortality or impairment of fertility up to one
year of age. Heterozygous and homozygous pups often
looked smaller than their normal littermates, but, as there
was no consistent correlation in weight differences be-
tween these groups, this observation reflected a difference
in coat appearance. The identical phenotype elicited by
both the full-length and the NH2-terminally deleted form
of plakoglobin argues strongly that the latter acts as an ac-
tive form of plakoglobin and not by interfering with the
function of endogenous plakoglobin.
Analysis of Hair
Hairs plucked from the heads of 25-d sex-matched F1
transgenic and control littermates were examined under a
dissecting microscope. We first asked whether the appear-
ance of the transgenic mice resulted from lack of the
longer outer coat hairs. The percentage of each of three
major types of hair (guard, awl, and zigzag), however,
were represented to the same degree in both the trans-
genic animals and their normal littermates. All hair types
of the transgenic mice showed a striking reduction in size,
being 30–40% shorter than hairs of normal littermates of
the same age (Fig. 5 c and Table I). The root and tapered
ends of the hairs were clearly visible, ruling out the possi-
bility that the hairs were shorter due to fragility and break-
age. In zigzag hairs, all four segments were present but
each segment was shorter in the transgenic than in the
wild-type hairs. Moreover, the segments became progres-
sively more affected, with segments that formed first being
reduced in length by z20% and those formed last being
reduced by z50%. By scanning electron microscopy, the
structure of the cuticle of the coat hairs appeared normal.
However, transgenic hairs were composed of z20% fewer
cells than normal hairs and the cells were 14% smaller in
diameter. No significant differences were found between
the length of hairs in the different lines, suggesting that the
transgene dose was irrelevant beyond a critical threshold.
This was also suggested by the fact that homozygotes
could not be phenotypically distinguished from heterozy-
gotes.
Mechanistic Studies: PG and DN80PG Expression 
Results in Early Withdrawal from the Growing Phase 
(Anagen) of the Hair Follicle Cycle, Reduction in 
Cycling Cells, Premature Apoptosis, and Follicle 
Degeneration but Not from Changes in the 
Differentiation Program
Histology. To search for a basis for the unusual length of
hairs from the transgenic mice, we examined skin from the
mid-back region of two to three pairs of normal and trans-
genic littermates from each line at multiple time intervals
throughout the first 41 d encompassing the first two hair
cycles. Up to day 11 there was no discernible difference in
the histological appearance of the transgenic epidermis or
primordial follicles from those of normal littermates. The
length and width of the follicular bulb, number, spacing,
Figure 5.  DN80PG (a) and
21-d PG (b) transgenic
mouse (left) compared with
their normal littermates
(right). Note the short hair
and pink hue of the transgen-
ics. (c) Hair from 25-d nor-
mal (N) and DN80PG (TG)
mice.The Journal of Cell Biology, Volume 149, 2000 512
and angling of the hair follicles was similar and in cross-
sections of epidermis the follicle density appeared identi-
cal in both groups. However, remarkable differences were
observed during later stages of anagen. In this strain of
mice (Swiss Webster) anagen begins late in gestation
zE17 and peaks around day 14 as estimated by follicle
length (see below). At day 13 normal mouse skin shows
the classical features of the anagen phase of the hair cycle
with the epithelial component of the follicle bulb contain-
ing large numbers of cells in mitotis (see arrows in Fig. 6
a). In contrast, by day 13 transgenic hair follicles have al-
ready entered into catagen and display large numbers of
involuting follicles trailing compact dermal papilla (Fig. 6
b). As a result the dermis of the transgenic skin becomes
much thinner than the normal. Hair follicles from normal
skin do not enter catagen until day 15 (Fig. 6 c) at which
time the follicles of the transgenic skin have already fully
regressed and entered the quiescent telogen phase (Fig. 6
d). Follicle lengths were measured, from the base of the
follicle bulb to the epidermis, to quantify the first two hair
cycles (Fig. 7). A similar but more attenuated scenario is
seen in the second cycle. Transgenic mice enter the second
cycle slightly ahead of their normal counterparts but again
leave earlier (Fig. 7). All transgenic lines showed this
trend.
Proliferation.  To determine the effects of DN80PG ex-
pression on cellular proliferation in epidermis and hair fol-
licles we undertook a double (pulse) labeling procedure.
Double (pulse) labeling gives information both on the
number of cells cycling at any one time and the number of
cells that have undergone two rounds of DNA synthesis
(Lehrer et al., 1998). Mice were first injected with BrdU
then 24 h later injected with 3H-TdR. A statistically signif-
icant decrease was observed in the number of labeled cells
in the transgenic group of mice (8.9 6 4.5) as compared
with their wild-type littermates (11.6 6 3.1; P  ,  0.001
Table I. Lengths (mm) 6 Standard Deviations of Hairs
Awl Guard Zigzag
Line No. of mice N TG N TG N TG
DNPG no. 4 6 5.6 6 0.43 3.6 6 0.45 8.1 6 0.99 5.8 6 0.68 5.0 6 0.32 3.3 6 0.29
DNPG no. 9 6 5.7 6 0.46 3.6 6 0.44 8.4 6 0.93 6.0 6 0.80 4.9 6 0.45 3.3 6 0.29
DNPG no. 45 3 5.5 6 0.42 3.7 6 0.34 8.2 6 1.16 5.6 6 0.61 4.9 6 0.37 3.3 6 0.30
PG no. 21 3 5.5 6 0.34 4.3 6 0.66 7.7 6 0.58 7.1 6 0.79 4.9 6 0.34 4.0 6 0.53
Pelage hairs of three (line nos. 45 and 21) to six (lines nos. 4 and 9) pairs of 25-d sex-matched F1 normal littermate (N) and transgenic mice (TG). Values represent means 6 stan-
dard deviations of the total lengths of five hairs of guard type and ten hairs of awl and zigzag types from 3–6 mice. The P value was ,0.001 for awl and zigzag hairs and 0.002 ,
P , 0.01 for guard hairs. Each type of hair from transgenic mice was 30–40% shorter compared with the normal littermates.
Figure 6. Histopathology of
transgenic mice. 5-mm paraf-
fin-embedded sections of
backskin from sex-matched
control and DN80PG trans-
genic F1 littermates were
stained with hematoxylin and
eosin (a–d). (a) 13-d control
hair follicles show the classi-
cal features of anagen, large
numbers of well-formed hair
follicle bulbs surrounding
dermal papilla. Many matrix
cells in the follicular bulbs
contain mitoses (see arrows
in a inset). In contrast 13-d
transgenic hair follicles (b)
have already entered catagen
typified by the degenerative
appearance of the involuting
hair follicles trailing com-
pact dermal papillae (b in-
set). Normal mouse hair fol-
licles begin to enter catagen
at day 15 (c), whereas hair
follicles of 15-d transgenic
mice have already com-
pleted the involution pro-
cess and entered telogen (d).
Bar: (a–d) 250 mm; (insets)
80 mm.Charpentier et al. Plakoglobin and Proliferation 513
where the number [n] of mice in each group 5 10). More-
over a highly significant difference was seen in the number
of cells undergoing two S phases within a 24-h period (Fig.
8). In transgenic epidermis, 8.5 6 4.5% of cells initially la-
beled with BrdU were also labeled with 3H-TdR indicating
they had undergone two rounds of DNA synthesis as com-
pared with 13.4 6 4.8% of cells in normal epidermis (P ,
0.001 where n 5 10 mice in each group). Thus, a significant
decrease in cycling cells results from DN80PG expression.
Apoptosis. The factors governing the extremely rapid
and synchronous involution of hair follicles during catagen
are poorly understood, but are thought to involve an apop-
totic pathway (Lindner et al., 1997). We therefore investi-
gated whether the early involution observed by day 13 in
the hair follicles of mice expressing DN80PG results from
or is associated with premature onset of such a mecha-
nism. TUNEL analysis was performed to detect DNA
fragmentation as a marker of apoptotic nuclei in sections
of three pairs of transgenic and normal littermate epider-
mis. Representative pictures are shown (Fig. 9). In normal
epidermis, no apoptotic nuclei were observed until day 13
and at this stage they were restricted to a few clusters of
cells within the inner root sheath of the hair follicle. Apop-
totic nuclei were not observed in normal matrix kerati-
nocytes of the hair follicle until day 15 when the earliest
signs of catagen became obvious. TUNEL positive nuclei
reached a maximum at day 17 and were clustered around
the dermal papilla cells next to the hair matrix and in the
bulge isthmus. These results are similar to previous obser-
vations on normal epidermis (Lindner et al., 1997). In con-
trast we observed a small number of apoptotic nuclei at
day 11 in the inner root sheath of the transgenic hair folli-
cles, a few apoptotic nuclei were seen in the matrix kerati-
nocytes at day 13 reaching a peak at day 15. Apoptotic
changes occur two days earlier in the transgenic than in
normal hair follicles, with a time course in both groups
that reflects the stage of involution. In both groups apop-
totic nuclei first appear in the early stages of catagen as the
lower portion of the follicles begin to degenerate and
reach a maximum at mid catagen. Thus, in both groups
apoptotic changes detected by TUNEL accompany but do
not precede the changes observed histologically in the hair
follicles.
Differentiation. Changes in K10 and K16 expression
have recently been reported to lead to altered prolifera-
tive potential of keratinocytes and hair follicles in vivo and
in vitro (Paladini and Coulombe, 1998; Paramio et al.,
1999). To determine whether the transgenic mice exhib-
ited changes in the normal differentiation program of the
epidermis or hair follicles frozen sections of epidermis
were stained with a panel of antibodies. These included
antibodies against: keratins 5 and 14, which are synthe-
sized in the basal layers; keratin 1, which is expressed in
the suprabasal layers; keratin 6, which is expressed under
conditions of hyperproliferation; high sulfur hair proteins,
which are restricted to cells of the hair cuticle and loricrin
which is expressed in the granular layer. No detectable
changes were observed in response to transgene expres-
sion (Fig. 10).
Discussion
Our results show that modest expression of either PG or a
truncated DN80 form of plakoglobin in the basal cells of
the epidermis and outer root sheath of the hair follicle
stunts hair growth. The principal findings are that hair fol-
licles of these mice leave anagen prematurely, prolifera-
tion of epidermal and hair follicle keratinocytes is reduced
and apoptotic changes occur earlier than usual. These re-
sults are consistent with the hypothesis that plakoglobin
regulates aspects of cell proliferation as well as cell adhe-
sion in normal cells in vivo and raises the interesting possi-
bility that plakoglobin may assist in coordinating these cel-
lular functions.
The identity of the PG and DN80PG phenotype argues
that the latter acts as an active rather than dominant nega-
tive form of plakoglobin. This is reminiscent of the situa-
tion with b-catenin where the full-length and NH2-termi-
nally deleted forms act similarly in many experimental
signaling assays. The lack of dose dependency in the phe-
notype between four independent transgenic lines strongly
suggests that plakoglobin exerts its full effect on prolifera-
tion at a critical threshold and that expression above that
threshold is irrelevant. Such a feature suggests that there
Figure 7. Comparison of the first two hair follicle growth cycles
in K14-PG and K14-DN80PG transgenic mice and their normal
littermates. Hair follicle length corresponds to the length in mm
from the base of the hair follicle bulb to the epidermal surface.
Data shown represent the mean of measurements of five hair fol-
licles from each of three pairs of control and transgenic Swiss
Webster mice. Standard errors are indicated by bars. Notice in
both hair cycles that the hair follicles in transgenic mice enter
into catagen earlier compared with the normal control.The Journal of Cell Biology, Volume 149, 2000 514
are a limited number of binding sites to be occupied on
downstream effectors. This would be expected if plakoglo-
bin is acting, in a manner similar, or perhaps antagonis-
tic to the transcriptional role played by its close relative
b-catenin, by saturating the binding sites on promoters of
a limited set of target genes. That plakoglobin is capable of
this type of role is suggested by its ability to transactivate a
luciferase reporter gene. This transactivation capability
was observed even in keratinocytes, which make numer-
ous desmosomes that sequester the majority of plakoglo-
bin at the membrane.
Plakoglobin and Proliferation
Follicle stem cells reside in the bulge, a structure that lies
at the bottom of the permanent part of the hair follicle and
is continuous with the outer root sheath and basal layer of
epidermis (Cotsarelis et al., 1990; Morris and Potten,
1999). Bulge stem cells have been postulated to respond to
signals from the closely adjacent telogen dermal papilla by
transiently proliferating and producing a population of
transit amplifying cells that migrate downwards to regen-
erate the hair follicle (Cotsarelis et al., 1990; Sun et al.,
1991). Thus progenitor cells residing in the epidermal
basal layer and in the bulge structure and their immediate
transit amplifying progeny express the K14 promoter and
the transgene product. The principal effect of plakoglobin
expression is seen in the hair follicles and hairs rather than
the epidermis. This can be explained by the fact that follic-
ular cells divide at six times the rate of epidermal cells
(12 h for follicular keratinocytes versus 3 d for epidermal
keratinocytes), and so factors that regulate proliferation
will be more apparent in these structures (Lehrer et al.,
1998). It should be noted, however, that the proliferative
capacity of the basal epidermal keratinocytes was also re-
duced. Due to the much slower cell cycle time a morpho-
logical effect on the epidermis was not observed. How-
ever, we noted that the transgenic mice had taut skin
suggesting that the transgene effect on the proliferative
rate of epidermal cells might have restricted the surface
area of the epidermis rather than the vertical thickness,
which in haired animals consists essentially of only 2–3 lay-
ers of cells. The reduction in both the single labeling as
well as in the double labeling index demonstrates that the
transgene expression has reduced the number of transit
amplifying cells cycling at any given time and slowed their
rate of their proliferation (Lehrer et al., 1998). We pro-
pose that this reduction in proliferative capacity of transit
amplifying cells limits their capacity to regenerate full size
hair follicles or full-length hairs, which is seen most obvi-
ously at later stages of anagen due to the exponential na-
ture of the proliferative process. This is entirely consistent
with studies showing that overexpression of plakoglobin
reduced the tumorigenicity and growth rate of highly
transformed cell lines (Simcha et al., 1996). Our results ex-
tend these observations to show that even modest levels of
expression of either full-length or NH2-terminally deleted
forms of plakoglobin restricts the proliferative potential of
normal cells in vivo. This suggests that negative regulation
of proliferation may be a generalized function of plakoglo-
bin. These results contrast strikingly to the effects of over-
expressing  DN89-b-catenin in the same cells under the
Figure 8. Comparison of
BrdU- and 3H-TdR–labeled
nuclei of DN80PG trans-
genic and normal epidermis.
4-d DN80PG transgenic (left)
and normal littermates
(right) were subjected to sub-
cutaneous injection of BrdU
followed 24 h later by a simi-
lar injection of 3H-TdR. Ar-
rowheads indicate double-
labeled cells; arrows indicate
3H-TdR–labeled nuclei. (a
and b) epidermis; (c–d and
e–f) hair follicle in the
anagen phase of the hair
growth cycle. Few if any dou-
ble pulse-labeled cells are
seen in the TG epidermis (a)
compared with the normal
littermates (b). Likewise ma-
trix keratinocytes in trans-
genic hair follicles (c and d)
contain fewer double pulse-
labeled cells than normal lit-
termates (e and f). Overall,
there was a decrease in cy-
cling transit amplifying cells
in epidermis of transgenic
mice (a) compared with nor-
mal control (b).Charpentier et al. Plakoglobin and Proliferation 515
same promoter (Gat et al., 1998). Expression of a DN89-
b-catenin induces de novo hair follicles in mature haired
skin, suggesting that it may cause epidermal cells to retain
pluripotent stem cell potential and promote their ability to
proliferate in response to unknown factors, present in
haired regions of skin, that induce hair follicle formation
(Gat et al., 1998). Furthermore, DN89-b-catenin expres-
sion eventually induces two types of follicular tumor in
epidermis (Chan et al., 1999; Gat et al., 1998). Plakoglobin
appears therefore to act in the opposite fashion to DN89-
b-catenin by restricting the hair follicle’s potential for pro-
liferation.
DN80PG Does Not Act by Downregulating b-Catenin
Two studies have suggested that plakoglobin expression
modulates b-catenin levels and that plakoglobin’s signal-
ing capabilities relate to this action. In Xenopus, plakoglo-
bin expression was proposed to sequester APC and, thus,
protect b-catenin from degradation and promote its sig-
naling function (Miller and Moon, 1997). This is clearly
not the case in epidermis, as full-length plakoglobin and
DN80PG do not produce a b-catenin phenotype. In the
second study, plakoglobin overexpression in HT1080 cells
downregulated b-catenin levels, and was hypothesized to
do this by competitively displacing b-catenin from the low
Figure 9. Apoptotic changes
detected by TUNEL staining
occur earlier in the matrix
cells of transgenic hair folli-
cles. Paraffin embedded sec-
tions from the backskin of
K14-DN80PG and control lit-
termates were subjected to
TUNEL staining to deter-
mine DNA fragmentation
during apoptotic cell death.
No apoptotic nuclei are seen
in the matrix keratinocytes of
the wild-type day 13 hair fol-
licles which are at the peak of
anagen. In transgenic litter-
mates of the same age, the
hair follicles are in catagen
and a few apoptotic nuclei
can be seen (arrows). By day
15 wild-type hair follicles be-
gin to enter catagen and a
few apoptotic nuclei are
found close to the trailing
dermal papilla. Day 15 trans-
genic hair follicles are in the
last stages of catagen and
contain many apoptotic nu-
clei. Apoptotic nuclei reach a
maximum by day 15 in the
transgenic and by day 17 in
normal mice. Bar, 25 mm.The Journal of Cell Biology, Volume 149, 2000 516
levels of cadherin present in these cells thereby exposing
the b-catenin to the cytosolic degradation machinery (Salo-
mon et al., 1997). However, in keratinocytes DN80PG
does not appreciably decrease the levels of endogenous
b-catenin or plakoglobin leading us to conclude that the
effect of DN80PG on proliferation does not involve down-
regulation of b-catenin. This raises the possibility that pla-
koglobin and DN80PG may antagonize b-catenin’s ability
to transactivate/derepress genes such as myc and cyclin D
that are involved in growth promotion, and/or modulate
the cell’s response to b-catenin signaling by stimulating in-
tersecting cadherin and/or growth factor mediated path-
ways at the membrane.
Plakoglobin and Wnt
The dramatic difference between the effects of plakoglo-
bin/DN80PG and DN89-b-catenin expression raises the
question as to which of these Armadillo homologues is the
downstream effector of Wnts in epidermis and its append-
ages. This is a complex issue as many Wnt genes (Wnt-3, 4,
7a, 10a, 10b and 11) as well as proteins involved in Wnt-
signal transduction (Dvl-1, 2, Lef-1, and Tcf-3) have been
described in embryonic or adult epidermis and its append-
ages (Bitgood and McMahon, 1995; Cygan et al., 1997; Gat
et al., 1998; Millar, 1997; Millar et al., 1999; Wang and
Shackleford, 1996). Some of these Wnts are known, in
other systems, to act through alternative and possibly an-
tagonistic pathways, and, Wnt cascades are subject to a
highly complex system of negative regulation at each step
(van Genderen et al., 1994; Wong et al., 1994; Du et al.,
1995; Zhou et al., 1995; Kratochwil et al., 1996; Brown and
Moon, 1998). Significantly, the K14-PG and K14-DN80PG
mice show a strikingly similar phenotype to that observed
in mice expressing K14-Wnt-3 or K14-Dvl-2 (see Millar et
al., 1999; Fig. 4). Specifically, all four mice display an iden-
tical short hair phenotype. K14-Wnt-3 mice display addi-
tional cyclical balding that is not seen in K14-Dvl-2, K14-
PG, or K14-DN80PG mice. This additional phenotype
results from paracrine activation of Wnt cascades in more
distant cells of the hair follicle that produce hair shaft
structural defects. The short hair phenotype, however, that
is common to all four mice, is independent of this process,
and, as Dvl2, PG, and DN80PG are, by their cytoplasmic
nature, restricted to the cells that express them must result
from an initial effect on cells of the outer root sheath.
Taken together this suggests that plakoglobin may func-
tion downstream of Dvl-2 in an endogenous Wnt pathway
operating in outer root sheath cells, a cell type that has
previously been shown to play a role in limiting hair
growth (Hebert et al., 1994). While premature withdrawal
from anagen and changes in proliferative rate were not ob-
served in the K14-Wnt-3 or K14-Dvl-2 mice it is not clear
that a sufficient sample size of mice were investigated in
order to detect the subtle changes seen in the K14-PG
mice (Millar et al., 1999).
Figure 10. Expression of differentiation-specific markers in epidermis of transgenic compared with normal mice. 5-mm frozen sections
of newborn tail skin (a, b, a,9 and b9) or 7-d backskin (c–e and c9–e9) from sex-matched normal and K14-DN80PG transgenic F1 litter-
mates were stained with anti-K1 (K1) and anti-K5 (K5); anti-desmoplakin (DP), anti-loricrin (LOR), anti-K6 (K6) and anti-high sul-
phur protein (HS). Note that the differentiation markers tested are expressed normally in the transgenic epidermis. Bar: (a9–b) 30 mm;
(c9–e) 50 mm.The Journal of Cell Biology, Volume 149, 2000 517
Potential Effects of DN80PG at the Plasma Membrane
Our EM, immunofluorescence and biochemical studies
found no evidence that cell junctions were deleteriously
affected by expression of PG or DN80PG. However, as the
transgene products are found in all three subcellular frac-
tions of transgenic keratinocytes, we cannot rule out that
plakoglobin may additionally, or alternatively, exert its ef-
fects via enhancing the function of a transmembrane or cy-
toskeletal partner protein. Cytokeratin 10 and 16 have
been shown to lead to changes in keratinocyte prolifera-
tion and reduced number of hair follicles (Paladini and
Coulombe, 1998; Paramio et al., 1999).  No significant
changes were seen in the patterns of intermediate fila-
ments ruling out their possible involvement in the plako-
globin phenotype. No changes were seen in desmosomes
or in the expression levels of junctional proteins beyond a
slight upregulation of E-cadherin again suggesting that the
plakoglobin phenotype does not result from a deleterious
effect on cell adhesion. The marginal changes in E-cad-
herin expression may contribute to the proliferative and
apoptotic changes that are elements of the plakoglobin
phenotype: E-cadherin has been shown to decrease cell
proliferation (St. Croix et al., 1998). However, E-cadherin
has been variously reported to promote and prevent apop-
tosis (Wong et al., 1998; Carmeiet et al., 1999; Hermiston
et al., 1996; Pece et al., 1999). Moreover, genetic experi-
ments in flies show that apoptosis is induced by the tran-
scriptional functions rather than the adhesive functions of
Armadillo (Ahmed et al., 1998). Transgenic expression of
several cytokines and growth factors in skin produce
shortened hair as part of their phenotype and both EGFR
and FGF5 are known to regulate the timing of the end of
anagen (Vassar and Fuchs, 1991; Turksen et al., 1992; He-
bert et al., 1994; Murillas et al., 1995). Both plakoglobin
and b-catenin are known to bind to and be substrates for
the EGF receptor (Hoschuetzky et al., 1994). However, as
the EGFR is only transiently expressed during the early
stages of mouse hair development and the plakoglobin
phenotype is persistent a connection between these pro-
teins is unlikely to account for the plakoglobin phenotype
(Vassar and Fuchs, 1991). There is no reported connection
between plakoglobin and FGF5 expression. However, as
cadherins have been shown to stimulate FGFR activity in
other systems (Doherty et al., 1991; Doherty and Walsh,
1996), the possibility that plakoglobin enhancement of
E-cadherin expression might simulate an FGF5 pathway
must be considered. Development of DN80PG mice and
their derived keratinocytes now permits these potential
models to be tested both genetically and biochemically.
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